Skip to main content
Clinical Trials/IRCT138806282480N1
IRCT138806282480N1
Completed
Phase 2

Evaluation of the effect of calcitriol supplementation on glucose, insulin, hemoglobin A1C, lipid profile and oxidative stress markers in hyperlipidemic patients with type 2 diabetes mellitus, Shiraz, 2009

Shiraz university of medical sciences0 sites70 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Shiraz university of medical sciences
Enrollment
70
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age\>30 years, Hb.A1C\<8%, FBS\<160 mg/dl, Serum Calcium \< 10\.5 mg/dl, LDL\<150 mg/dl, normal liver and kidney function, no history of kidney stone, not taking insulin therapy, no hypercalcemia was seen.
  • Exclusion criteria: using vitamin D supplement, pregnancy, smoking, UVB exposure with therapeutic goals, acute kidney or liver disease, hypercalcemia, hyperparathyroidism.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials